NASDAQ:MTNB - Matinas Biopharma News Headlines

Sign in or create an account to add this stock to your watchlist.
$0.99 +0.01 (+1.02 %)
(As of 05/27/2019 06:00 AM ET)
Previous Close$0.9882
Today's Range$0.96 - $0.9899
52-Week Range$0.32 - $1.50
Volume613,801 shs
Average Volume1.09 million shs
Market Capitalization$141.25 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Matinas Biopharma (NASDAQ MTNB) News Headlines

Source:
DateHeadline
Have Insiders Been Buying Matinas BioPharma Holdings, Inc. (NYSEMKT:MTNB) Shares?Have Insiders Been Buying Matinas BioPharma Holdings, Inc. (NYSEMKT:MTNB) Shares?
finance.yahoo.com - May 22 at 3:28 PM
Matinas BioPharma Announces Abstract Accepted for Presentation at ASM Microbe 2019Matinas BioPharma Announces Abstract Accepted for Presentation at ASM Microbe 2019
finance.yahoo.com - May 21 at 3:27 PM
ViiV Healthcare to evaluate Matinas Bios LNC platformViiV Healthcare to evaluate Matinas Bio's LNC platform
seekingalpha.com - May 15 at 3:27 PM
Matinas BioPharma Holdings, Inc. (MTNB) CEO Jerry Jabbour on Q1, 2019 Results - Earnings Call TranscriptMatinas BioPharma Holdings, Inc. (MTNB) CEO Jerry Jabbour on Q1, 2019 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 3:31 PM
Matinas Biopharma (MTNB) to Release Earnings on TuesdayMatinas Biopharma (MTNB) to Release Earnings on Tuesday
www.americanbankingnews.com - May 12 at 9:33 AM
Matinas BioPharma to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational andMatinas BioPharma to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational and
www.nasdaq.com - May 8 at 3:26 PM
Matinas BioPharma to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational and Financial Results on May 14, 2019Matinas BioPharma to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational and Financial Results on May 14, 2019
finance.yahoo.com - May 8 at 3:26 PM
Matinas BioPharma to Ring NYSE Opening Bell® on May 6, 2019Matinas BioPharma to Ring NYSE Opening Bell® on May 6, 2019
finance.yahoo.com - May 2 at 3:25 PM
Matinas BioPharma Selected to Present at the BioNJ Ninth Annual BioPartnering ConferenceMatinas BioPharma Selected to Present at the BioNJ Ninth Annual BioPartnering Conference
finance.yahoo.com - May 1 at 3:25 PM
Matinas BioPharma Holdings IncMatinas BioPharma Holdings Inc
www.bloomberg.com - April 4 at 3:23 PM
Edited Transcript of MTNB earnings conference call or presentation 2-Apr-19 12:00pm GMTEdited Transcript of MTNB earnings conference call or presentation 2-Apr-19 12:00pm GMT
finance.yahoo.com - April 2 at 8:24 PM
Matinas BioPharma to Present at the 31st Annual ROTH ConferenceMatinas BioPharma to Present at the 31st Annual ROTH Conference
finance.yahoo.com - March 18 at 3:20 PM
Matinas Bio prices stock offering at $1.10; shares down 6% premarketMatinas Bio prices stock offering at $1.10; shares down 6% premarket
seekingalpha.com - March 15 at 3:19 PM
Matinas BioPharma Announces Pricing of Public Offering of Common StockMatinas BioPharma Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - March 15 at 3:19 PM
BRIEF-Matinas Biopharma Q2 loss per share $0.40BRIEF-Matinas Biopharma Q2 loss per share $0.40
www.businessinsider.com - August 9 at 1:29 AM
Investor Network: Matinas BioPharma Holdings, Inc. to Host Earnings CallInvestor Network: Matinas BioPharma Holdings, Inc. to Host Earnings Call
finance.yahoo.com - August 9 at 1:28 AM
Matinas BioPharma Reports 2017 Second Quarter Financial Results and Reaffirms Clinical and Regulatory Strategy to Advance MAT2203 and MAT2501Matinas BioPharma Reports 2017 Second Quarter Financial Results and Reaffirms Clinical and Regulatory Strategy to Advance MAT2203 and MAT2501
finance.yahoo.com - August 9 at 1:28 AM
Matinas BioPharma to Present at the Canaccord Genuity 37th Annual Growth ConferenceMatinas BioPharma to Present at the Canaccord Genuity 37th Annual Growth Conference
finance.yahoo.com - August 4 at 5:49 AM
Matinas BioPharma to Host Quarterly Update Conference CallMatinas BioPharma to Host Quarterly Update Conference Call
finance.yahoo.com - August 2 at 6:06 AM
Heres Why Matinas BioPharma Holdings Inc. Is Losing Ground TodayHere's Why Matinas BioPharma Holdings Inc. Is Losing Ground Today
www.fool.com - June 26 at 2:16 PM
BRIEF-Matinas Biopharma reports topline data from phase 2 clinical study of vaginal drugBRIEF-Matinas Biopharma reports topline data from phase 2 clinical study of vaginal drug
www.reuters.com - June 26 at 8:52 AM
Matinas BioPharma Holdings (MTNB) Presents At Jefferies 2017 Global Healthcare Conference - SlideshowMatinas BioPharma Holdings (MTNB) Presents At Jefferies 2017 Global Healthcare Conference - Slideshow
seekingalpha.com - June 13 at 6:50 PM
Matinas BioPharma Holdings (MTNB) Updates on MAT2203 - Interim Data From NIHMucocutaneous Candidiasis Phase 2 Study - SlideshowMatinas BioPharma Holdings (MTNB) Updates on MAT2203 - Interim Data From NIHMucocutaneous Candidiasis Phase 2 Study - Slideshow
seekingalpha.com - June 7 at 8:51 AM
MATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD DisMATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Dis
us.rd.yahoo.com - April 3 at 5:58 PM
BRIEF-Matinas Biopharma on track to report interim phase 2 data of MAT2203 in June 2017BRIEF-Matinas Biopharma on track to report interim phase 2 data of MAT2203 in June 2017
www.reuters.com - April 3 at 10:03 AM
Matinas BioPharma Reports 2016 Financial Results and Provides Corporate UpdateMatinas BioPharma Reports 2016 Financial Results and Provides Corporate Update
www.nasdaq.com - April 3 at 10:03 AM
Matinas Biopharma reports FY16 results; shares up 8% premarketMatinas Biopharma reports FY16 results; shares up 8% premarket
seekingalpha.com - April 3 at 10:03 AM
Q4 2016 Matinas BioPharma Holdings Inc Earnings Release - Before Market OpenQ4 2016 Matinas BioPharma Holdings Inc Earnings Release - Before Market Open
biz.yahoo.com - April 3 at 10:03 AM
MATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 10-K, Annual ReportMATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 31 at 6:47 PM
MATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD DisclosMATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclos
biz.yahoo.com - March 30 at 6:57 PM
Matinas BioPharma reports positive topline data from phase 1 study MAT2501; Shares +4%Matinas BioPharma reports positive topline data from phase 1 study MAT2501; Shares +4%
seekingalpha.com - March 28 at 6:28 PM
Matinas Biopharma Holdings (MTNB) Presents At 29th Annual ROTH ConferenceMatinas Biopharma Holdings (MTNB) Presents At 29th Annual ROTH Conference
seekingalpha.com - March 16 at 7:26 PM
Matinas BioPharma Announces Positive Preclinical Efficacy Results of MAT2501 in an In Vitro Model of Mycobacterium abscessus InfectionMatinas BioPharma Announces Positive Preclinical Efficacy Results of MAT2501 in an In Vitro Model of Mycobacterium abscessus Infection
us.rd.yahoo.com - March 8 at 9:46 AM
Matinas BioPharma Announces Trading on NYSE MKT to Commence March 2, 2017Matinas BioPharma Announces Trading on NYSE MKT to Commence March 2, 2017
us.rd.yahoo.com - February 27 at 5:59 PM
8:35 am Matinas BioPharma will commence trading on the NYSE on March 28:35 am Matinas BioPharma will commence trading on the NYSE on March 2
us.rd.yahoo.com - February 27 at 5:59 PM
Matinas Biopharma raises $13.5M through warrant tender offerMatinas Biopharma raises $13.5M through warrant tender offer
seekingalpha.com - January 20 at 3:10 AM
MATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Regulation FD DisclosureMATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Regulation FD Disclosure
biz.yahoo.com - January 19 at 10:09 PM
MATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a DirectMATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct
biz.yahoo.com - December 21 at 7:32 PM
Matinas Biopharma commences dosing in Phase 1 study of lead product candidate MAT2501Matinas Biopharma commences dosing in Phase 1 study of lead product candidate MAT2501
seekingalpha.com - December 5 at 6:44 PM
Matinas BioPharma Registers Shares, Prepares For Critical TrialsMatinas BioPharma Registers Shares, Prepares For Critical Trials
seekingalpha.com - November 11 at 6:00 PM
This page was last updated on 5/27/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel